Centene (CNC) vs Oscar Health (OSCR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Centene (CNC) has outperformed Oscar Health (OSCR) over the past year, gaining 67.9% versus a gain of 51.8%. Over five years, OSCR leads with a +108.8% price change compared with -1.2% for CNC. Centene is the larger company by market cap ($32.45 billion vs $10.30 billion), about 3.2 times the size, while Oscar Health is growing revenue faster (+27.5% vs +19.4%).
On valuation, Centene trades at a lower forward P/E (12.3x vs 15.4x for Oscar Health). Centene converts more of its revenue into profit, with a net margin of -3.4% versus -3.8%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNC | OSCR |
|---|---|---|
| Share price | $65.69 | $33.37 |
| Market cap | $32.45B | $10.30B |
| 1-day change | +1.78% | +0.82% |
| YTD return | +56.84% | +130.34% |
| 1-year return | +67.85% | +51.83% |
| 5-year return | -1.19% | +108.83% |
| P/E ratio (TTM) | — | 25.87 |
| Forward P/E | 12.28 | 15.41 |
| EPS (TTM) | $-10.44 | $1.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $194.78B | $11.70B |
| Revenue growth (YoY) | +19.44% | +27.50% |
| Net income (latest FY) | $-6.67B | $-443.15M |
| Gross margin | 7.30% | — |
| Operating margin | -3.91% | -3.39% |
| Net margin | -3.43% | -3.79% |
| 52-week high | $69.63 | $34.48 |
| 52-week low | $31.63 | $10.69 |
| Distance from 52-week high | -5.66% | -3.22% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +9.27% | +6.08% |
| Average volume | 4.56M | 5.20M |
| Shares outstanding | 494.00M | 273.47M |
| Employees | 61,100 | 2,305 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Centene is about 3.2 times larger than Oscar Health by market value ($32.45B vs $10.30B).
- CNC has outperformed OSCR by 16.0 percentage points over the past year.
- Oscar Health grew revenue faster in its latest fiscal year (+27.50% vs +19.44%).
About Centene
CNC stock →Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other.
Health Care · Medical Specialities · 61,100 employees
About Oscar Health
OSCR stock →Oscar Health, Inc. operates as a healthcare technology company in the United States.
Health Care · Medical Specialities · 2,305 employees
CNC vs OSCR FAQ
Which is bigger, Centene or Oscar Health?
Centene (CNC) is larger, with a market capitalization of $32.45B compared with $10.30B for Oscar Health (OSCR).
Which stock has performed better over the past year, CNC or OSCR?
CNC returned +67.85% over the past 12 months, compared with +51.83% for OSCR (price return, excluding dividends). Past performance does not predict future results.
Are Centene and Oscar Health in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.